Serum glycated albumin as good biomarker for predicting type 2 diabetes: A retrospective cohort study of China National Diabetes and Metabolic Disorders Survey,Diabetes/Metabolism Research and Reviews

当前位置： X-MOL 学术 › Diabetes Metab. Res. Rev. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Serum glycated albumin as good biomarker for predicting type 2 diabetes: A retrospective cohort study of China National Diabetes and Metabolic Disorders Survey
Diabetes/Metabolism Research and Reviews ( IF 4.6 ) Pub Date : 2021-05-26 , DOI: 10.1002/dmrr.3477
Yuanyuan Bai ₁ , Yujie Fang ₁ , Jie Ming ₁ , Huigang Wei ₁ , Pinghua Zhang ₁ , Juan Yan ₁ , Yongfeng Du ₁ , Qiaoyue Li ₁ , Xinwen Yu ₁ , Minglan Guo ₁ , Shengru Liang ₁ , Ruofan Hu ₁ , Qiuhe Ji ₁

Affiliation

Glycated albumin (GA) is a biomarker for short-term (2–3 weeks) glycaemic control. However, the predictive utility of GA for diabetes and prediabetes is largely uncharacterised. We aimed to investigate the relationships of baseline serum GA levels with incident diabetes and prediabetes.

更新日期：2021-05-26

点击分享查看原文

点击收藏

阅读更多本刊最新论文